View in EDS HTML Full Text PDF Full Text

N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses.

Saved in:
Bibliographic Details
Title: N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses.
Authors: Aritsu Y; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Kitabatake M; Department of Immunology, Nara Medical University, Nara, Japan., Kurose A; Department of Applied Chemistry, Faculty of Science and Engineering, Kindai University, Osaka, Japan., Hamana H; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan., Nakama T; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Yamada K; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Furukawa R; Department of Immunology, Nara Medical University, Nara, Japan., Ouji-Sageshima N; Department of Immunology, Nara Medical University, Nara, Japan., Hara A; Department of Immunology, Nara Medical University, Nara, Japan., Yasuike K; Department of Immunology, Nara Medical University, Nara, Japan., Itami S; Graduate School of Science and Engineering, Kindai University, Osaka, Japan., Li H; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Udaka K; Department of Immunology, Kochi University, Kochi, Japan., Kishi H; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan., Ueno T; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan., Nakagawa S; Department of Molecular Life Science, Tokai University School of Medicine, Kanagawa, Japan., Ito T; Department of Immunology, Nara Medical University, Nara, Japan., Kawashita N; Department of Energy and Materials, Faculty of Science and Engineering, Kindai University, Osaka, Japan., Kitamatsu M; Department of Applied Chemistry, Faculty of Science and Engineering, Kindai University, Osaka, Japan., Motozono C; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 27; Vol. 17, pp. 1758642. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42125653
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aritsu+Y%22">Aritsu Y</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Kitabatake+M%22">Kitabatake M</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Kurose+A%22">Kurose A</searchLink>; Department of Applied Chemistry, Faculty of Science and Engineering, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hamana+H%22">Hamana H</searchLink>; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Nakama+T%22">Nakama T</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Yamada+K%22">Yamada K</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Furukawa+R%22">Furukawa R</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Ouji-Sageshima+N%22">Ouji-Sageshima N</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Hara+A%22">Hara A</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Yasuike+K%22">Yasuike K</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Itami+S%22">Itami S</searchLink>; Graduate School of Science and Engineering, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Udaka+K%22">Udaka K</searchLink>; Department of Immunology, Kochi University, Kochi, Japan.<br /><searchLink fieldCode="AU" term="%22Kishi+H%22">Kishi H</searchLink>; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.<br /><searchLink fieldCode="AU" term="%22Ueno+T%22">Ueno T</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22Nakagawa+S%22">Nakagawa S</searchLink>; Department of Molecular Life Science, Tokai University School of Medicine, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Ito+T%22">Ito T</searchLink>; Department of Immunology, Nara Medical University, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Kawashita+N%22">Kawashita N</searchLink>; Department of Energy and Materials, Faculty of Science and Engineering, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kitamatsu+M%22">Kitamatsu M</searchLink>; Department of Applied Chemistry, Faculty of Science and Engineering, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Motozono+C%22">Motozono C</searchLink>; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Apr 27; Vol. 17, pp. 1758642. <i>Date of Electronic Publication: </i>2026 Apr 27 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42125653
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1758642
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1758642
    Titles:
      – TitleFull: N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aritsu Y
      – PersonEntity:
          Name:
            NameFull: Kitabatake M
      – PersonEntity:
          Name:
            NameFull: Kurose A
      – PersonEntity:
          Name:
            NameFull: Hamana H
      – PersonEntity:
          Name:
            NameFull: Nakama T
      – PersonEntity:
          Name:
            NameFull: Yamada K
      – PersonEntity:
          Name:
            NameFull: Furukawa R
      – PersonEntity:
          Name:
            NameFull: Ouji-Sageshima N
      – PersonEntity:
          Name:
            NameFull: Hara A
      – PersonEntity:
          Name:
            NameFull: Yasuike K
      – PersonEntity:
          Name:
            NameFull: Itami S
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Udaka K
      – PersonEntity:
          Name:
            NameFull: Kishi H
      – PersonEntity:
          Name:
            NameFull: Ueno T
      – PersonEntity:
          Name:
            NameFull: Nakagawa S
      – PersonEntity:
          Name:
            NameFull: Ito T
      – PersonEntity:
          Name:
            NameFull: Kawashita N
      – PersonEntity:
          Name:
            NameFull: Kitamatsu M
      – PersonEntity:
          Name:
            NameFull: Motozono C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 04
              Text: 2026 Apr 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1